Salbutamol 20 mg 100 tablets oral steroids tablets

Description

Salbutamol Beta-2 Adrenergic Agonist Research

Chemical Properties

• CAS Number: 18559-94-9 (Base) / 51022-70-9 (Sulfate)
• Molecular Formula: $C_{13}H_{21}NO_{3}$
• Molecular Weight: 239.31 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Fine white to off-white crystalline powder

How It Works

The biochemical activity of Salbutamol is defined by its selective interaction with the $beta_2$-subtype of adrenergic receptors located primarily in bronchial smooth muscle and adipose tissue. At the molecular level, the molecule binds to the receptor, triggering a conformational shift in the G-protein coupled receptor (GPCR) complex. This defines the first semantic triple: [Salbutamol agonizes $beta_2$-adrenergic receptors]. Following this, this activation stimulates the enzyme adenylate cyclase, resulting in the rapid conversion of ATP to cyclic adenosine monophosphate (cAMP). This establishes the second triple: [GPCR activation increases intracellular cAMP]. Thirdly, elevated cAMP levels activate protein kinase A (PKA), which phosphorylates target proteins to induce muscle relaxation and activate hormone-sensitive lipase. This forms the third triple: [Elevated cAMP promotes lipolysis and bronchodilation]. Quantitatively, Salbutamol possesses a systemic half-life of approximately 4 to 6 hours ($t_{1/2}=5.0pm1.0$h) in research models. In comparative studies, Salbutamol is distinguished from Clenbuterol by its significantly shorter half-life, offering a more manageable model for investigating acute metabolic spikes versus chronic receptor downregulation.

Product Profile

Salbutamol, also known as Albuterol, is a synthetic phenethylamine derivative and a highly selective $beta_2$-adrenergic receptor agonist. This signaling molecule serves as a primary research benchmark for investigating the modulation of smooth muscle relaxation and the stimulation of metabolic thermogenesis. [Salbutamol agonizes beta-2 adrenergic receptors]. Its structural configuration allows for high-fidelity studies on cAMP-mediated signaling pathways and their downstream effects on lipolysis and respiratory kinetics.

Research Observations

• Targeted Bronchodilation: Users in research models report rapid relaxation of airway smooth muscle, optimizing oxygen intake parameters.
• Acute Thermogenesis: Study data demonstrates a transient increase in core body temperature and basal metabolic rate.
• Lipolysis Stimulation: Based on community feedback, research models show enhanced mobilization of free fatty acids from adipose stores.
• Myofibrillar Preservation: Cumulative findings indicate potential anti-catabolic properties, helping maintain lean tissue during caloric deficits.
• Glycogenolysis Activation: Research models have observed an accelerated breakdown of glycogen into glucose for immediate energy utilization.

Summary:
Salbutamol Oral represents a high-feasibility research tool for investigating the acute activation of beta-2 adrenergic signaling and the molecular pathways of thermogenesis and smooth muscle relaxation.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.